From: The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
The clinicopathological characteristics | N | % | |
---|---|---|---|
Group age (Years) | ≤60 | 37 | 39.78% |
> 60 | 55 | 59.14% | |
Unknown | 1 | 1.08% | |
Gender | Male | 77 | 82.80% |
Female | 16 | 17.20% | |
Tumor Grade | High Grade | 56 | 60.22% |
Low Grade | 29 | 31.18% | |
Unknown | 8 | 8.60% | |
Cancer type | MIBC | 52 | 55.91% |
NMIBC | 28 | 30.11% | |
Unknown | 13 | 13.98% | |
Subtypes | Transitional | 74 | 79.57% |
Squamous | 3 | 3.23% | |
Transitional/ Squamous | 15 | 16.13% | |
Unknown | 1 | 1.08% | |
Tumor Shape | Papillary | 63 | 67.74% |
Non-papillary | 3 | 3.23% | |
Unknown | 27 | 29.03% | |
Lymph Node | Positive | 21 | 22.58% |
Negative | 68 | 73.12% | |
Unknown | 4 | 4.30% | |
Vascular Invasion | Positive | 18 | 19.35% |
Negative | 70 | 75.27% | |
Unknown | 5 | 5.38% | |
Metastasis | Positive | 21 | 22.58% |
Negative | 67 | 72.04% | |
Unknown | 5 | 5.38% | |
Smoking | No | 11 | 11.83% |
Yes | 16 | 17.20% | |
Unknown | 66 | 70.97% | |
Family history of cancer | No | 24 | 25.81% |
Yes | 4 | 4.30% | |
Unknown | 65 | 69.89% | |
Survival | Alive | 65 | 69.89% |
Deceased | 28 | 30.11% |